CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing concerns over zoonotic diseases
4.1.2. Rising prevalence of animal diseases
4.1.3. Increasing livestock population and growing awareness about animal health
4.1.4. Increasing demand for animal-derived food products
4.1.5. Innovations in animal healthcare products
4.2. Market Restraints & Challenges
4.2.1. Lack of awareness among pet users
4.2.2. High vaccine storage costs
4.2.3. Stringent approval processes for animal healthcare products
4.2.4. Growing resistance to parasiticides and antibiotics
4.3. Market Opportunities
4.3.1. Rising adoption of pet health insurance and growth in companion animal ownership
4.3.2. Lucrative growth opportunities in emerging economies
4.3.3. Consolidation in the animal health industry
CHAPTER 5. GLOBAL ANIMAL HEALTH MARKET – BY ANIMAL TYPE
5.1. Production Animal
5.1.1. Poultry
5.1.1. Swine
5.1.2. Cattle
5.1.3. Fish
5.1.4. Sheep & Goats
5.2. Companion Animal
5.2.1. Dogs
5.2.2. Cats
5.2.3. Horses
5.2.4. Others
CHAPTER 6. GLOBAL ANIMAL HEALTH MARKET – BY PRODUCT
6.1. Growth Promoters
6.1.1. Antibiotic
6.1.2. Hormonal
6.1.3. Feed Enzyme
6.1.4. Beta-Agonist
6.1.5. Prebiotics & Probiotics
6.1.6. Phytogenics
6.1.7. Others
6.2. Feed Additives/Nutritional Products
6.2.1. Amino Acids
6.2.2. Binders
6.2.3. Vitamins
6.2.4. Feed Acidifiers
6.2.5. Minerals
6.2.6. Antioxidants
6.2.7. Others
6.3. Vaccines
6.3.1. Inactivated
6.3.2. Live attenuated
6.3.3. Toxoid
6.3.4. Recombinant
6.3.5. Conjugate
6.3.6. Subunit
6.4. Antimicrobials and Antibiotics
6.4.1. Penicillin’s
6.4.2. Tetracyclines
6.4.3. Cephalosporins
6.4.4. Macrolides
6.4.5. Aminoglycosides
6.4.6. Sulfonamides
6.4.7. Others
6.5. Parasiticides
6.5.1. Endoparasiticides
6.5.1.1. Oral Liquids
6.5.1.2. Oral Solids
6.5.1.3. Injectables
6.5.1.4. Feed Additives
6.5.1.5. Others
6.5.2. Ectoparasiticides
6.5.2.1. Sprays
6.5.2.2. Dips
6.5.2.3. Ear Tags
6.5.2.4. Oral Tablets
6.5.2.5. Others
6.5.3. Endectocides
6.6. Others
CHAPTER 7. GLOBAL ANIMAL HEALTH MARKET – BY DISTRIBUTION
CHANNEL
7.1. Retail
7.2. E-Commerce
7.3. Hospital Pharmacy
CHAPTER 8. GLOBAL ANIMAL HEALTH MARKET – BY END USER
8.1. Reference Laboratories
8.2. Point-of-care Testing/In-House Testing
8.3. Veterinary Hospitals & Clinics
8.4. Others
CHAPTER 9. GLOBAL ANIMAL HEALTH MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL ANIMAL HEALTH MARKET - COMPANY PROFILES
10.1. Bayer AG
10.2. Zoetis, Inc.
10.3. Merck &Co., Inc.
10.4. Sanofi
10.5. Boehringer Ingelheim GmbH
10.6. Eli Lilly and Company
10.7. Virbac Group
10.8. Cargill Inc.
10.9. Ceva Sante Animale
10.10. Vetoquinol S.A.
10.11. IDEXX Laboratories
10.12. Merial
10.13. Elanco Animal Health
10.14. Novartis Animal Health
10.15. CareFusion
CHAPTER 11. GLOBAL ANIMAL HEALTH MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
